Welcome to our dedicated page for Jack Nathan Med news (Ticker: JNHMF), a resource for investors and traders seeking the latest updates and insights on Jack Nathan Med stock.
Jack Nathan Medical Corp. reports corporate and operating developments tied to its transition from a retail medical clinic network to a Canadian MedSpa-focused business. The company, also known as Jack Nathan Health, operates MedSpa clinics in Canada and has exited its Canadian primary care and licensee business and its Walmart Mexico clinic operations.
Recurring news themes include IFRS financial results, restructuring actions, balance sheet optimization, discontinued operations, leadership changes, and strategic reviews. Updates also cover the capital structure effects of legacy financing arrangements and the company's efforts to stabilize operations after divestitures and clinic closures.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF") announced that all matters voted at the annual general meeting on December 23, 2022, were approved by shareholders. All nominees for the board of directors were elected with strong support, receiving over 97% approval. Key resolutions included the reappointment of MNP LLP as auditors and amendments to the Omnibus Equity Incentive Plan, allowing grants of restricted stock units to executives. The company operates extensive healthcare networks in Canada and Mexico, enhancing patient access through clinics in Walmart locations.
Jack Nathan Medical Corp. (JNHMF) reported a 77% increase in Q3 fiscal 2023 revenues, totaling $4.2 million, compared to Q3 fiscal 2022. For the nine months ending October 31, 2022, revenues reached $11.8 million, marking a 110% growth year-over-year. Operating losses decreased from $1.5 million in Q2 to $0.9 million in Q3. Clinic operations generated 79% of revenues, reflecting successful acquisitions and reduced COVID-19 restrictions. As of October 31, 2022, JNH's cash position improved to $1.6 million, with total assets at $8.5 million and liabilities at $7.5 million.
Jack Nathan Medical Corp. (TSXV: JNH; OTCQB: JNHMF) has adjourned its annual and special meeting of shareholders (AGM) to December 23, 2022, at 1:30 p.m. Toronto time. The meeting will now be held in person at Dickinson Wright LLP, allowing shareholders to better comply with the Company’s advance notice by-law, which has extended the notice period to December 12, 2022. Jack Nathan Health operates as a significant healthcare network in Canada, providing convenient access to medical services within Walmart locations.
Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) reported Q2 FY2023 revenues of $3.6 million, an 87% increase compared to Q2 FY2022. Clinic operations revenue surged 198%, driven by growth from recently acquired clinics. For the six months ended July 31, 2022, total revenues reached $7.5 million, reflecting a 135% increase. The company achieved a significant reduction in net loss before income taxes to (2.66 million) from (3.5 million) year-over-year. Operating expenses rose to $10.1 million due to expanded clinic operations.